Fidelity Investments’s Biomerica BMRA Stock Holding History

Fidelity Investments’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6	Closed	-$16	–	5560
2024 Q3	$16	Buy	+6	New	+$17	﹤0.01%	5381
2021 Q3	–	Hold	0	–	–	–	4359
2021 Q2	–	Hold	0	–	–	–	4257

Other funds holding BMRA

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments's BMRA Position: Q4 2024 in Review

Fidelity Investments sold out of Biomerica (BMRA) in Q4 2024, closing a stake of 6 shares — an estimated $16 sold.

Fidelity Investments first reported a position in BMRA in Q3 2024 and held it in 1 quarter. The position peaked at $16 in Q3 2024. 21 funds tracked by Wall St. Rank hold BMRA as of Q4 2024.

Fidelity Investments reported no remaining Biomerica position as of Q4 2024 after selling out during the quarter.
Fidelity Investments sold 6 Biomerica shares in Q4 2024, an estimated $16.
Fidelity Investments first reported a position in Biomerica in Q3 2024 and held it in 1 quarter.
Fidelity Investments's Biomerica position peaked at $16 in Q3 2024.
21 funds tracked by Wall St. Rank held Biomerica as of Q4 2024.

Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.